Shaozhan Chen
Fujian Key Laboratory Of Precision Medicine For Cancer
Fuzhou, China
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Indirubin suppresses ovarian cancer progression by inhibiting PI3K/AKT-mediated EMT and tumor growth without systemic toxicity.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 03, 2025
BST2 Drives Epithelial Ovarian Cancer Progression via Macrophage M2 Polarization, Neural Remodeling, and Immunosuppressive Microenvironment Formation.
Journal: Human mutation
Published: July 24, 2025
Beyond oocyte quantity: the paradoxical role of poor ovarian response in live birth outcomes among endometriosis patients undergoing IVF/ICSI-ET.
Journal: Journal of assisted reproduction and genetics
Published: June 19, 2025
Indirubin induces apoptosis in ovarian cancer cells via the mitochondrial pathway.
Journal: American journal of translational research
Published: July 18, 2024
Analysis of Clinical Characteristics and Prognostic Factors Related to EMs Correlation in Ovarian Cancer Patients.
Journal: Alternative therapies in health and medicine
Published: January 30, 2024
Effect of Vaginal Microecological Alterations on Female Pelvic Organ Prolapse.
Journal: International urogynecology journal
Published: October 18, 2023
HMGB1 enhances the migratory and invasive abilities of A2780/DDP cells by facilitating epithelial to mesenchymal transition via GSK‑3β.
Journal: Experimental and therapeutic medicine
Published: February 21, 2023
Long non-coding RNA MYU promotes ovarian cancer cell proliferation by sponging miR-6827-5p and upregulating HMGA1.
Journal: Pathology oncology research : POR
Published: October 07, 2022
Emodin Reverses the Epithelial-Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway.
Journal: Drug design, development and therapy
Published: May 25, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026